Complete guide to GCC cancer care services — oncology service delivery, chemotherapy management, radiotherapy, cancer screening programmes, DHA oncology standards, Saudi cancer strategy, and oncology software.
GCC has 100,000+ new cancer cases per year. Cancer is the #2 cause of death. 120+ LINACs across the GCC (below IAEA target). This guide covers GCC cancer care services.
GCC Cancer Care Components
| Component | Description | Availability |
|---|---|---|
| Medical oncology | Chemotherapy, targeted therapy, immunotherapy | All tertiary GCC hospitals |
| Radiation oncology | External beam radiotherapy, brachytherapy | Tertiary hospitals (120+ LINACs) |
| Surgical oncology | Cancer surgery — breast, colorectal, etc. | Tertiary hospitals |
| Paediatric oncology | Childhood cancer treatment | Specialist centres (10+ in GCC) |
| Cancer screening | Breast, colorectal, cervical screening | DHA, Saudi national programmes |
| Palliative care | Cancer palliative and end-of-life care | Limited — expanding |
| Cancer genetics | Hereditary cancer risk assessment | Specialist centres |
| Clinical trials | Cancer clinical trials | Major centres (KFSH, SKMC) |
Cancer Care Pathway
- Screening/referral: Screening programme or GP referral for suspected cancer
- Diagnosis: Biopsy, imaging, staging — target: within 28 days of referral
- MDT review: Multi-disciplinary team review for treatment plan
- Treatment: Surgery, chemotherapy, radiotherapy, targeted therapy, immunotherapy
- Follow-up: Regular follow-up with surveillance imaging and tumour markers
- Survivorship: Long-term follow-up, rehabilitation, psychosocial support
- Palliative care: Symptom management and end-of-life care for advanced cancer
Chemotherapy Safety Standards
| Standard | Description | Mandatory? |
|---|---|---|
| Chemotherapy ordering | Electronic chemotherapy ordering with protocols | Yes (DHA, JCI) |
| Dose calculation | BSA-based, weight-based dose calculation with checks | Yes |
| Preparation | Chemotherapy prepared in isolator/clean room | Yes |
| Administration | Trained oncology nurse, patient identification | Yes |
| Extravasation protocol | Extravasation management protocol | Yes |
| Toxicity monitoring | Regular blood counts, organ function | Yes |
| Cold chain | Temperature-controlled storage and transport | Yes |
Frequently Asked Questions
- What is the cancer burden in the GCC?
- GCC cancer burden: 100,000+ new cancer cases per year. Most common cancers: breast (25% of female cancers), colorectal (12%), lung (10%), prostate (8%), thyroid (6%). Cancer is the #2 cause of death in the GCC (after CVD). Saudi Vision 2030 and DHA are investing in cancer care infrastructure.
- What cancer screening programmes exist in the GCC?
- GCC cancer screening: 1) Breast cancer — mammography every 2 years for women 40-69 (DHA, Saudi), 2) Colorectal — FIT every 2 years for 50-74 (DHA), 3) Cervical — Pap smear every 3 years for 25-49 (DHA, Saudi). Saudi also has national breast cancer screening programme. Screening uptake is 30-50% (below 70% target).
- How many radiotherapy machines are in the GCC?
- GCC has 120+ linear accelerators (LINACs): Saudi Arabia — 60+, UAE — 25+, Qatar — 8+, Kuwait — 6+, Bahrain — 4+, Oman — 4+. IAEA recommends 1 LINAC per 250,000 population. GCC has 1 per 500,000 — below target. Saudi and UAE are expanding radiotherapy capacity.